Search research articles
Contact Us
Filters
Showing results (141-150 of 213) with videos related to
Page
of 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
William D Tap, Victor M Villalobos, Gregory M Cote, et al.
Communications Biology
|
March 9, 2022
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma
Christopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
The American Journal of Surgical Pathology
|
June 11, 2021
Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue Tumors
Ivan Chebib, Martin S Taylor, Valentina Nardi, et al.
Scientific Reports
|
March 12, 2020
MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma
Christopher E Lietz, Cassandra Garbutt, William T Barry, et al.
Sarcoma
|
August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
Future Oncology (London, England)
|
February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
Gregory M Cote, Sant P Chawla, George Demetri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2026
A Phase 2 Study of the Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Gregory M Cote, Mason Aberoumand, Edwin Choy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeutics
Christopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
Science Advances
|
March 31, 2023
Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity
Rajendran Sanalkumar, Rui Dong, Lukuo Lee, et al.
Nature Communications
|
March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Page
of 22
Search research articles
Search
Showing results (141-150 of 213) with videos related to
Sort By:
Page
of 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 27, 2020
Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma
William D Tap, Victor M Villalobos, Gregory M Cote, et al.
Communications Biology
|
March 9, 2022
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma
Christopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
The American Journal of Surgical Pathology
|
June 11, 2021
Clinical Utility of Anchored Multiplex Solid Fusion Assay for Diagnosis of Bone and Soft Tissue Tumors
Ivan Chebib, Martin S Taylor, Valentina Nardi, et al.
Scientific Reports
|
March 12, 2020
MicroRNA-mRNA networks define translatable molecular outcome phenotypes in osteosarcoma
Christopher E Lietz, Cassandra Garbutt, William T Barry, et al.
Sarcoma
|
August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
Future Oncology (London, England)
|
February 11, 2025
SaLudo: a randomized phase IIb/III study of lurbinectedin plus doxorubicin as first-line treatment in leiomyosarcoma
Gregory M Cote, Sant P Chawla, George Demetri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 2, 2026
A Phase 2 Study of the Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Gregory M Cote, Mason Aberoumand, Edwin Choy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 1, 2024
A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeutics
Christopher E Lietz, Erik T Newman, Andrew D Kelly, et al.
Science Advances
|
March 31, 2023
Highly connected 3D chromatin networks established by an oncogenic fusion protein shape tumor cell identity
Rajendran Sanalkumar, Rui Dong, Lukuo Lee, et al.
Nature Communications
|
March 26, 2026
Tazemetostat, an EZH2 inhibitor, in solid tumors harboring SWI/SNF alterations: a phase II basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Page
of 22